Evidence map›Paper›PMID 29200431›Full record

ArticlePloS one2017

Post-illumination cellular effects of photodynamic treatment.

Malak Charara, Artak Tovmasyan, Ines Batinic-Haberle, James Craik, Ludmil Benov

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Malak ChararaDepartment of Biochemistry, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait.
Artak TovmasyanDepartment of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, United States of America.
Ines Batinic-HaberleDepartment of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, United States of America.
James CraikDepartment of Biochemistry, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait.
Ludmil BenovDepartment of Biochemistry, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait.ORCID http://orcid.org/0000-0002-0205-0146
Kuwait University · KWDuke Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increased interest in clinical application of photodynamic therapy (PDT) in various medical fields poses a demand for better understanding of processes triggered by photo-treatment. Most of the work on PDT performed so far has focused on the immediate effects of photo-treatment. It is generally accepted that cellular damage occurs during light exposure and within a short period thereafter. If cells are not killed during the PDT, they might recover, depending on the extent of the photo-induced damage. Little is known, however, about the relationship between the properties of photosensitizers (PSs) and the delayed consequences of PDT. The aim of this work was to investigate cellular responses to sub-lethal photodynamic treatment and how toxicogenic potency may be affected by molecular features of the PS. Results demonstrated that for cationic porphyrin-based PSs, lipophilicity is the main factor determining the fate of the cells in the 24-hour post-illumination period. PSs with amphiphilic properties initiated oxidative reactions that continued in the dark, long after light exposure, and caused suppression of metabolism and loss of cell viability with concomitant changes in electrophoretic mobility of proteins, including caspases. Apoptotic activity was not stimulated in the post-illumination period. This study demonstrated that in PDT mediated by amphiphilic cationic metalloporphyrin PSs, even when immediate photo-damage is relatively mild, destructive oxidative processes initiated during PDT continue in the absence of light to substantially impair metabolism, and that post-illumination protein modification may modify utilization of cell death pathways.

Indexed as

ApoptosisCell DeathCell SurvivalHumansLightMCF-7 CellsMetalloporphyrinsOxidation-ReductionPhotochemotherapyPhotosensitizing AgentsProtein Processing, Post-TranslationalSignal TransductionSurface-Active AgentsMetalloporphyrinsPhotosensitizing AgentsSurface-Active Agents

Identifiers

PMID29200431
PMCPMC5714340
OpenAlexW2774812992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.